SCHEMBL6649722

SCHEMBL6649722

CCCc1ccncc1-c1nc(-c2ccc(OC(F)(F)F)cc2)cs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF2 Q12772 5/20 0.46
ATP4A P20648 4/20 0.43
ATP4B P51164 4/20 0.43
CYP19A1 P11511 2/20 0.42
ALOX5 P09917 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649359 0.92 CYP19A1 (0.46) ATP4AATP4BCYP19A1ALOX5HDAC3
SCHEMBL6628492 0.86 SREBF2 (0.61) SREBF2ATP4AATP4BCYP19A1RAB9A
SCHEMBL6628971 0.85 KDM4E (0.51) SREBF2ATP4AATP4BCYP19A1RAB9A
SCHEMBL6648508 0.84 KDM4E (0.51) SREBF2CYP19A1RAB9AMAPTKMT2A
SCHEMBL6649838 0.83 KDM4E (0.59) SREBF2CYP19A1ALOX5RAB9AMAPT
SCHEMBL6649085 0.81 KDM4E (0.59) SREBF2CYP19A1RAB9AMEN1MAPT
SCHEMBL6649370 0.81 CYP19A1 (0.46) SREBF2CYP19A1RAB9AMEN1MAPT
SCHEMBL6650443 0.81 SREBF2 (0.55) SREBF2ATP4AATP4BCYP19A1RAB9A
SCHEMBL6647164 0.81 KDM4E (0.59) SREBF2ATP4AATP4BCYP19A1RAB9A
SCHEMBL6649374 0.81 SREBF2 (0.59) SREBF2CYP19A1RAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed